Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study
暂无分享,去创建一个
S. Scholten | B. Wynne | M. Ait-Khaled | Don E. Smith | Jesús Santos | A. Tenorio | F. Ajana | M. Wohlfeiler | M. Nascimento | J. van Wyk | Bryn Owen Jones | Jonathan Wright | M. Ait‐Khaled